RecruitingNot ApplicableNCT02988921

MRI and CT Simulation in the Evaluation of Tumor Response and Target Volume Definition for Esophageal or Esophagogastric Cancer Patients Undergoing Chemoradiotherapy


Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Enrollment

300 participants

Start Date

Oct 1, 2016

Study Type

INTERVENTIONAL

Conditions

Summary

Magnetic resonance imaging (MRI) with functional features of diffusion weighted imaging (DWI) are advancing imaging technologies that have potential to overcome limitations of conventional staging methods, radiation treatment planning and the assessment of tumor response in esophageal or esophagogastric cancer. This study aimed to explore the value of MRI for the prediction of tumor response to chemoradiotherapy and accurate target volume delineation as compared to CT simulation for patients with unresectable or potentially resectable esophageal or esophagogastric cancer undergoing chemoradiotherapy. The average CT texture features are also extracted before and during treatment to establish a model to predict the prognosis or side effects (e.g. radiation pneumonitis or esophagitis) of patients.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is using MRI and CT scans taken at different points during chemoradiation therapy (a combination of chemotherapy and radiation) to track how esophageal (food pipe) or stomach-junction cancers respond to treatment, and to plan radiation more accurately. **You may be eligible if...** - You have been diagnosed with squamous cell or adenocarcinoma of the esophagus or where the esophagus meets the stomach - Your tumor cannot be removed by surgery, or surgery may be possible after treatment - Your cancer is at a locally advanced stage (no spread to distant organs except possibly neck lymph nodes) - You are over 18 years of age - You have not had previous chest radiation or chemotherapy - Your blood, liver, and kidney function are within acceptable levels **You may NOT be eligible if...** - Your cancer has spread to distant organs - You have had prior chemotherapy or radiation to the chest - Your organ function is too poor to safely receive chemoradiation Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEMRI and CT
RADIATIONRatiotherapy
DRUGPaclitaxel, platinum-based drug

Locations(1)

Department of Radiation Oncology, Cancer Hospital, National Cancer Center, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC)

Beijing, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02988921


Related Trials